Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,442Revenue (TTM) $M1,600Net Margin (%)41.0Altman Z-Score10.4
Enterprise Value $M4,276EPS (TTM) $14.3Operating Margin %60.1Piotroski F-Score5
P/E(ttm)8.5Beneish M-Score-2.6Pre-tax Margin (%)60.0Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %33.5Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow7.9y-y EBITDA Growth Rate %-26.2ROA % (ttm)28.4Higher Current Ratio y-yN
Dividend Yield %--PEG0.3ROE % (ttm)35.4Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.1ROIC % (ttm)79.8Gross Margin Increase y-yN

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

UTHR is held by these investors:



UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & CEO 2017-05-18Sell1,261$120.720.61view
ROTHBLATT MARTINE AChairman & CEO 2017-05-11Sell1,259$122-0.44view
ROTHBLATT MARTINE AChairman & CEO 2017-05-04Sell1,258$122.24-0.64view
ROTHBLATT MARTINE AChairman & CEO 2017-04-27Sell1,262$120.780.56view
ROTHBLATT MARTINE AChairman & CEO 2017-04-20Sell1,260$121.140.26view
ROTHBLATT MARTINE AChairman & CEO 2017-04-13Sell1,258$122.12-0.54view
ROTHBLATT MARTINE AChairman & CEO 2017-04-06Sell1,257$122.39-0.76view
ROTHBLATT MARTINE AChairman & CEO 2017-03-30Sell1,230$134.56-9.74view
ROTHBLATT MARTINE AChairman & CEO 2017-03-23Sell1,219$139.33-12.83view
Thompson Tommy GDirector 2017-03-22Sell2,000$139.37-12.85view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update May 12 2017 
United Therapeutics Announces $250 Million Share Repurchase Program Apr 27 2017 
United Therapeutics Corporation Reports First Quarter 2017 Financial Results Apr 26 2017 
3D Systems and United Therapeutics Announce Bioprinting Agreement Apr 26 2017 
United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market Ope Apr 19 2017 
United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump Apr 03 2017 
United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patent Mar 31 2017 
Gurus Invest in Undervalued Biotech Stocks Nov 25 2016 
6 Undervalued Stocks Trading Below the Peter Lynch Value Oct 26 2016 
These Five Stocks Show a Combination of Value and Growth Aug 03 2016 

More From Other Websites
United Therapeutics reworks deal ahead of a key patent's expiration May 19 2017
Blog Coverage: Ionis Pharma Reported Positive Phase III Results in Patients with Familial Amyloid... May 16 2017
ETFs with exposure to United Therapeutics Corp. : May 15, 2017 May 15 2017
SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update May 12 2017
United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 May 01 2017
United Therapeutics' Martine Rothblatt saw pay jump last year amid executive shakeup May 01 2017
United Therapeutics partners with 3-D printer to make human organs Apr 28 2017
Edited Transcript of UTHR earnings conference call or presentation 26-Apr-17 1:00pm GMT Apr 28 2017
United Therapeutics Announces $250 Million Share Repurchase Program Apr 27 2017
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss Apr 27 2017
Blog Coverage3D Systems and United Therapeutics Partner to Develop 3D Bioprinted Lungs Apr 27 2017
These Greater Washington companies may be most affected by Trump's tax reform Apr 26 2017
3D Systems signs 'bioprinting' agreement to eventually create human organs Apr 26 2017
United Therapeutics beats 1Q profit forecasts Apr 26 2017
3D Systems and United Therapeutics Announce Bioprinting Agreement Apr 26 2017
United Therapeutics Corporation Reports First Quarter 2017 Financial Results Apr 26 2017
Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More Apr 25 2017
Rising Revenue and Earnings: Mistubishi Financial, United Therapeutics Apr 19 2017
United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market... Apr 19 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat